يعرض 1 - 11 نتائج من 11 نتيجة بحث عن '"uric acid/ec [Endogenous Compound]"', وقت الاستعلام: 0.39s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29054
    New England Journal of Medicine
    Click here for full text options
    LibKey Link

  4. 4
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29054
    New England Journal of Medicine
    LibKey Link

  5. 5
  6. 6
  7. 7
    Electronic Resource
  8. 8
    Electronic Resource
  9. 9
  10. 10
  11. 11
    Electronic Resource

    المؤلفون: Spernat D., Kourambas J.

    مصطلحات الفهرس: kidney colic/dt [Drug Therapy], kidney colic/th [Therapy], low fat diet, mental health, nephrotic syndrome/si [Side Effect], pancytopenia/si [Side Effect], priority journal, prophylaxis, protein restriction, purine metabolism, rash/si [Side Effect], recurrent disease/dt [Drug Therapy], recurrent disease/pc [Prevention], risk reduction, side effect/si [Side Effect], sodium restriction, stone dissolution, stone formation/dt [Drug Therapy], stone formation/pc [Prevention], thrombosis/si [Side Effect], ureter stone/dt [Drug Therapy], urolithiasis/dt [Drug Therapy], urolithiasis/th [Therapy], weight reduction, acetohydroxamic acid/ae [Adverse Drug Reaction], acetohydroxamic acid/dt [Drug Therapy], alfuzosin/cm [Drug Comparison], alfuzosin/dt [Drug Therapy], allopurinol/dt [Drug Therapy], alpha adrenergic receptor blocking agent/cm [Drug Comparison], alpha adrenergic receptor blocking agent/dt [Drug Therapy], bicarbonate/dt [Drug Therapy], bicarbonate/po [Oral Drug Administration], calcium/ec [Endogenous Compound], calcium channel blocking agent/dt [Drug Therapy], cellulose phosphate/ae [Adverse Drug Reaction], cellulose phosphate/dt [Drug Therapy], citrate potassium/ae [Adverse Drug Reaction], citrate potassium/cb [Drug Combination], citrate potassium/dt [Drug Therapy], citrate potassium/po [Oral Drug Administration], citric acid/dt [Drug Therapy], corticosteroid/cm [Drug Comparison], corticosteroid/dt [Drug Therapy], deflazacort/cm [Drug Comparison], deflazacort/dt [Drug Therapy], doxazosin/cm [Drug Comparison], doxazosin/dt [Drug Therapy], nifedipine/ct [Clinical Trial], nifedipine/cm [Drug Comparison], nifedipine/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], oxalic acid/ec [Endogenous Compound], penicillamine/ae [Adverse Drug Reaction], penicillamine/cm [Drug Comparison], penicillamine/dt [Drug Therapy], placebo, potassium dihydrogen phosphate/dt [Drug Therapy], scopolamine butyl bromide, tamsulosin/ct [Clinical Trial], tamsulosin/cm [Drug Comparison], tamsulosin/dt [Drug Therapy], terazosin/cm [Drug Comparison], terazosin/dt [Drug Therapy], thiazide diuretic agent/cb [Drug Combination], thiazide diuretic agent/dt [Drug Therapy], tiopronin/ae [Adverse Drug Reaction], tiopronin/cm [Drug Comparison], trometamol/dt [Drug Therapy], uric acid/ec [Endogenous Compound], tiopronin/dt [Drug Therapy], bone pain/si [Side Effect], acid secretion, article, asthenia/si [Side Effect], calcium intake, calcium oxalate stone/dt [Drug Therapy], calcium urine level, cystinuria/dt [Drug Therapy], dermatitis/si [Side Effect], fluid intake, gastrointestinal symptom/si [Side Effect], human, hypercalciuria/dt [Drug Therapy], hypocoagulability/si [Side Effect], Article